LAURA DOOLEY: Open Payments
NPI 1780983130 · ADA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$529 in 22 payments from 14 companies in 2025. Trend: 2023 $41 · 2024 $181 · 2025 $529
Food & beverage: $486Education: $43
| Company | Payments | Amount |
|---|---|---|
| Mannkind Corporation | 3 | $85 |
| Insulet Corporation | 1 | $75 |
| Sequel Med Tech, LLC | 3 | $58 |
| Lilly USA, LLC | 3 | $50 |
| Xeris Pharmaceuticals, Inc. | 2 | $43 |
| BETA BIONICS, INC. | 2 | $42 |
| Madrigal Pharmaceuticals | 1 | $37 |
| Corcept Therapeutics | 1 | $25 |
| Antares Pharma, Inc. | 1 | $24 |
| SANOFI-AVENTIS U.S. LLC | 1 | $23 |
Products named: AFREZZA, Omnipod, TWIIST, MOUNJARO, GVOKE HYPOPEN, iLet Bionic Pancreas, REZDIFFRA, Korlym.
Industry payments across OK — which companies pay providers there.
